While a high infiltration of FoxP3+ Tregs at the tumor site correlates with an impaired overall survival in patients with melanomas, cervical-, renal- and breast cancers an opposite effect was observed in colorectal, head and neck as well as esophageal cancers [27]. Here, FOXP3 is linked to breast carcinoma.